众力资讯网

🔻 疫苗批号刚刚暴露了一个模式。而且这不是随机的。**2026年6月28日。上

🔻 疫苗批号刚刚暴露了一个模式。而且这不是随机的。

**2026年6月28日。上午07:42。** 研究人员将12,000个疫苗批号与VAERS不良事件报告进行了交叉引用。他们发现:特定批次的不良事件相关性显著高于其他批次。

这不是阴谋。这是数据。

**数据揭示了什么**

相关性是存在的。这是已记录的。

以20A-20F结尾的批号:报告的不良事件最少以21K-21X结尾的批号:不良事件升高(心肌炎、血栓、入院)以22R-22Z结尾的批号:不良事件浓度最高

这个模式是真实的。问题是:为什么?

**隐藏的调查**

制药行业联系人告诉我:FDA知道这个模式。

他们已经知道好几个月了。

但他们没有说的是:这些批次的分配并非随机。

高不良事件批次被不成比例地分配到:▪️ 军事基地▪️ 急救人员设施▪️ 农村社区▪️ 特定人口统计集群

低不良事件批次分配给了:▪️ 政府官员▪️ 媒体人物▪️ 制药高管▪️ 他们的家人

**真正的问题**

这是制造不一致?还是故意的?

制药供应链联系人告诉我:你不可能通过意外得到三个明显的层级。

要么:1. 质量控制失败(不太可能)2. 分配是有意的(数据表明这一点)

**时间线**

- **2021-2022:** 批次分配- **2023-2024:** 不良事件模式显现- **2025:** FDA知晓- **2026:** 数据分析完成- **现在:** 研究人员发布发现

**掩盖**

监管机构内部联系人告诉我:多家期刊拒绝同行评审。不是因为方法论有缺陷。因为发现“政治敏感”。

研究人员直接发布了它。数据现在公开。

12,000个批号。每个分配点。每个不良事件相关性。每个医院。每个州。

FDA无法抹除这个记忆。数据已分布在网络中。

这就是他们惊慌的原因。

**接下来会发生什么**

国会将调查。这个分配模式太具体,无法忽视。

如果是随机的制造差异,分配应该是随机的。但并非如此。

如果是故意的,那就是另一番对话。

无论如何,数据要求答案。

VACCINE-LOT-PATTERN-0628ADVERSE-EVENTS-CORRELATEDDISTRIBUTION-QUESTIONED

批号就是证据。分配就是模式。不良事件就是结果。

你认识的某个人得到的配方与他们被告知的不同。分享这个。

🔻 VACCINE LOT NUMBERS JUST EXPOSED A PATTERN. AND IT'S NOT RANDOM.

**June 28, 2026. 07:42 AM.** Researchers cross-referenced 12,000 vaccine lot numbers with VAERS adverse event reports. What they found: specific batches had significantly higher adverse event correlations than others.

This isn't conspiracy. This is data.

**WHAT THE DATA SHOWS**

The correlation exists. That's documented.

Lot numbers ending in 20A-20F: minimal adverse events reportedLot numbers ending in 21K-21X: elevated adverse events (myocarditis, blood clots, hospitalizations)Lot numbers ending in 22R-22Z: highest adverse event concentrations

The pattern is real. The question is: WHY?

**THE HIDDEN INVESTIGATION**

I've been told by pharmaceutical industry contacts: The FDA knows about this pattern.

They've known for months.

But here's what they're NOT saying: The distribution of these lots wasn't random.

The high-adverse-event batches were disproportionately distributed to:▪️ Military bases▪️ First responder facilities▪️ Rural communities▪️ Specific demographic clusters

The low-adverse-event batches went to:▪️ Government officials▪️ Media figures▪️ Pharmaceutical executives▪️ Their families

**THE REAL QUESTION**

Was this manufacturing inconsistency? Or deliberate?

I've been told by pharmaceutical supply chain contacts: You don't get THREE DISTINCT TIERS by accident.

Either:1. Quality control failed (unlikely)2. Distribution was intentional (data suggests this)

**THE TIMELINE**

- **2021-2022:** Lots distributed- **2023-2024:** Adverse event patterns emerged- **2025:** FDA became aware- **2026:** Data analysis complete- **NOW:** Researchers releasing findings

**THE COVER-UP**

I've been told by contacts inside regulatory agencies: Multiple journals rejected peer review. Not because methodology was flawed. Because findings were "politically sensitive."

The researchers released it directly. The data is now public.

12,000 lot numbers. Every distribution point. Every adverse event correlation. Every hospital. Every state.

The FDA cannot memory-hole this. Data is distributed across networks.

This is why they're panicking.

**WHAT HAPPENS NEXT**

Congress will investigate. The distribution pattern is too specific to ignore.

If random manufacturing variance, distribution would be random. It wasn't.

If intentional, that's a different conversation.

Either way, the data demands answers.

VACCINE-LOT-PATTERN-0628ADVERSE-EVENTS-CORRELATEDDISTRIBUTION-QUESTIONED

The lot numbers are the evidence. The distribution is the pattern. The adverse events are the outcome.

Someone you know got a different formula than they were told. Share this.